KRISTIN STOK: Open Payments
NPI 1619411576 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 47 payments from 15 companies in 2025. Trend: 2023 $13 · 2024 $51 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $240 |
| Teva Pharmaceuticals USA, Inc. | 1 | $102 |
| Novo Nordisk Inc | 5 | $91 |
| PFIZER INC. | 5 | $90 |
| Phathom Pharmaceuticals, Inc. | 6 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $81 |
| Astellas Pharma US Inc | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
Products named: AUSTEDO XR, VRAYLAR, NURTEC ODT, VOQUEZNA, GVOKE HYPOPEN, QULIPTA, UBRELVY, Wegovy.
Industry payments across IN — which companies pay providers there.
